XML 88 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2016 $ 33,021 $ 1 $ 186,494 $ 87 $ (153,561)
Begining balance, Shares at Dec. 31, 2016   100,486,000      
Common stock issued upon stock option exercise $ 153   153    
Common stock issued upon stock option exercise, Shares 35,352 35,000      
Common stock issued upon vesting of restricted stock units, net $ (6,934)   (6,934)    
Common stock issued upon vesting of restricted stock units, net, Shares   879,000      
Repurchase of common stock (144)   (144)    
Repurchase of common stock, Shares   (11,791)      
Forfeiture of restricted stock awards (80)   (80)    
Forfeiture of restricted stock awards, Shares   (5,000)      
Stock-based compensation expense 38,105   38,105    
Comprehensive loss (68) [1]     (68)  
Net loss (24,010)       (24,010)
Ending balance at Dec. 31, 2017 40,043 $ 1 217,594 19 (177,571)
Ending balance, Shares at Dec. 31, 2017   101,383,000      
Cumulative-effect adjustment upon adoption | Accounting Standards Update 2017-09     (43)   43
Issuance of common stock in connection with initial public offering, net 225,336 $ 0 225,336 0 0
Issuance of common stock in connection with initial public offering, net, Shares   20,583,000      
Common stock issued upon stock option exercise $ 494   494    
Common stock issued upon stock option exercise, Shares 81,849 82,000      
Common stock issued upon vesting of restricted stock units, net $ (25,807)   (25,807)    
Common stock issued upon vesting of restricted stock units, net, Shares   3,771,000      
Repurchase of common stock (16)   (16)    
Repurchase of common stock, Shares   (1,159)      
Stock-based compensation expense 134,379   134,379    
Comprehensive loss (306) [1]     (306)  
Net loss (154,740)       (154,740)
Ending balance at Dec. 31, 2018 219,383 $ 1 551,937 (287) (332,268)
Ending balance, Shares at Dec. 31, 2018   125,818,000      
Cumulative-effect adjustment upon adoption | ASC 842 3,411       3,411
Common stock issued upon stock option exercise $ 47,678   47,678    
Common stock issued upon stock option exercise, Shares 3,733,401 3,733,000      
Common stock issued upon vesting of restricted stock units, net, Shares   3,661,000      
Common stock issued in connection with acquisition $ 36,204   36,204    
Common stock issued in connection with acquisition, shares   2,320,000      
Common stock issued under employee stock purchase plan 5,344   5,344    
Common stock issued under employee stock purchase plan, shares   506,000      
Stock-based compensation expense 63,748   63,748    
Comprehensive loss (157) [1]     (157)  
Other 232   232    
Other, shares   16,000      
Net loss (73,859)       (73,859)
Ending balance at Dec. 31, 2019 $ 301,984 $ 1 $ 705,143 $ (444) $ (402,716)
Ending balance, Shares at Dec. 31, 2019   136,054,000      
[1] Net of tax effect which was not material.